Ampofo, W.K.Azziz-Baumgartner, E.Bashir, U.Cox, N.J.Fasce, R.Giovanni, M.Grohmann, G.Huang, S.Katz, J.Mironenko, A.Mokhtari-Azad, T.Sasono, P.M.Rahman, M.Sawanpanyalert, P.Siqueira, M.Waddell, A.L.Waiboci, L.Wood, J.Zhang, W.Ziegler, T.2018-11-192018-11-192015-07-03W.K. Ampofo et al.2015. Strengthening the influenza vaccine virus selection and development process Vaccine 33 (2015) 4368–4382http://dx.doi.org/10.1016/j.vaccine.2015.06.090http://ugspace.ug.edu.gh/handle/123456789/25580ArticleDespite long-recognized challenges and constraints associated with their updating and manufacture, influenza vaccines remain at the heart of public health preparedness and response efforts against both seasonal and potentially pandemic influenza viruses. Globally coordinated virological and epidemiological surveillance is the foundation of the influenza vaccine virus selection and development process. Although national influenza surveillance and reporting capabilities are being strengthened and expanded, sustaining and building upon recent gains has become a major challenge. Strengthening the vaccine virus selection process additionally requires the continuation of initiatives to improve the timeliness and representativeness of influenza viruses shared by countries for detailed analysis by the WHO Global Influenza Surveillance and Response System (GISRS).enInfluenza vaccine virusesVaccine virus selectionWHO recommendationsArticle